Background: Common diseases, particularly dementia, have large social costs for the U.S. population. However, less is known about the end-of-life costs of specific diseases and the associated financial risk for individual households.
T
he recent reduction in Medicare growth rates, coupled with a decline in the fraction of the total U.S. health care bill paid out-of-pocket by patients, might suggest that U.S. health care (and Medicare, more specifically) is protecting older persons from catastrophic health care expenses (1) (2) (3) . Yet little is known about the total social costs (personal out-of-pocket costs plus external or governmental costs [4] ) and the household financial burdens of care in the last years of life. The evidence is limited to spending from only 1 insurance program (Medicare) (5, 6) or focuses only on out-ofpocket spending, whether as a fraction of total health spending (7) or in terms of dollars spent (8) . One important study measured the differential effect of dementia on total health care costs (9) , but the researchers did not quantify the financial risks faced by patients with dementia among vulnerable subgroups of the population and did not consider financial risks for persons who died of other diseases. Despite proposals to introduce voucher or premium support plans that could entail greater out-of-pocket cost sharing for older persons or shift expenses to other government or private payers (10 -12) , little is known about the extent of end-of-life, health-related financial risk faced by individual households or the overall cost burden to government and private health insurance.
Here, we consider the social costs and financial risks faced by Medicare beneficiaries during the 5 years before death. We consider various social costs associated with disease, such as government (Medicare and Medicaid) spending, private insurance, out-of-pocket expenditures, and informal care. We also examine how these spending components in the last 5 years of life vary across 4 disease groups: dementia, cancer, heart disease, and other conditions. To address this question, we use the HRS (Health and Retirement Study), which is a nationally representative longitudinal cohort study of U.S. adults older than 50 years funded by the National Institute on Aging. The HRS includes detailed information on out-of-pocket spending, total Medicare spending, insurance coverage, socioeconomic status, health and cognitive status, and cause of death.
questions on the participant's demographic characteristics, social and functional characteristics, medical information, caregiving needs and hours of support, and financial information. The HRS also links patient survey data to individual Medicare claims records and the National Death Index. We sampled all HRS decedents identified by a postdeath proxy interview between 2006 and 2010 (n = 4086). We combined these data with each decedent's interview data (on average 2 interviews) from the previous 5 years.
To examine Medicare spending during the last 5 years of life, we excluded respondents younger than 70 years at the time of death (n = 851) and those who died outside of the study period of 1 January 2005 to 31 December 2010 (n = 267). We also excluded persons without linked Medicare claims data (n = 113), those who lacked continuous fee-for-service Medicare Parts A and B coverage during the 5 years preceding death (n = 103), and those who did not provide information about entitlement for the full 60 months before the date of death (n = 75). We were not able to use persons with Medicare Part C (that is, Medicare Advantage) because complete claims data for this group are not available (n = 792). Finally, we excluded persons who had no core interviews in the 5 years preceding death (n = 77), those with no dementia probability estimate (n = 100), and those who lived outside of the United States (n = 6). The final sample included 1702 persons.
Total out-of-pocket expenses were summed across all categories and scaled to comprise a consistent 60-month (5-year) period (8, 13) . The study period was defined for each person by his or her date of death and the 60 months preceding that date. Because HRS surveys are done approximately every 2 years, the sum of months does not have to be exactly 60 months. As in our earlier study, when the spending reported in the HRS surveys exceeded the 60-month look-back period, we adjusted spending to a 60-month period by prorating expenses and use reported in the earliest HRS interview-the period farthest from death and thus likely to have the lowest cost (8) . For example, if the period covered by the HRS surveys comprised 64 months, with the earliest survey reflecting a 28-month (rather than a 24-month) period, we prorated the spending and use reported in that survey (by 24/28) to adjust total health care spending to a 60-month period.
Groups were determined as follows: Persons were assigned to the dementia group if the probability of dementia at the last available assessment (on average 24 months before death) exceeded 50%. This probability is provided by the HRS and reflects an algorithm formulated by its investigators that is based on multiple cognitive measures; methods are reported elsewhere (9, 14) . We and others use this probabilistic approach because so few decedents are coded as having died of dementia-most are identified on death records as having died of something else. We did sensitivity tests using alternative probability cutoffs for defining the dementia group, specifically probabilities of 70% or greater and 90% or greater. Decedents in the nondementia group were assigned to 3 groups according to the cause of death obtained by the HRS from the National Death Index: cancer, heart disease, or other conditions.
Health-related out-of-pocket spending is measured every 2 years in the HRS core interviews and again in the postdeath interview, in which it is reported by the decedent's surviving spouse, family members, or other knowledgeable proxy. Specific categories of spending include insurance, hospital, physician, medication, nursing home, hired helpers, in-home medical care, and other expenses. We measured total Medicare expenditures in the last 5 years of life, including all claims for inpatient, outpatient, skilled-nursing facility, hospice, home care, and durable medical equipment. We collected data on other insurance coverage (Medicaid, private Medigap and long-term care policies, and Veterans Health Administration coverage) and household wealth from HRS surveys. When respondents did not know the exact amount spent on a specific item, they could instead report a range (for example, between $2000 and $10 000). In these cases, we followed the methods described by Marshall and colleagues (13) and used HRS data to impute a mean value for that individual.
The total number of nights spent in a nursing home was reported in the HRS interviews and summed across the 5 years preceding death. Using the average private payer cost of a night in a nursing home within the person's state (15) , we first estimated the number of nights paid based on reported nursing home out-of-pocket spending. Using Medicare claims and Medicare expenditures data, we then accounted for the number of nights covered by Medicare. The remaining nights were attributed to either a private payer or Medicaid (adjusted to the lower state-based Medicaid price), based on whether the person was eligible for Medicaid
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at that time. This imputation procedure has been described separately (9) .
To account for the implicit cost of caregiving beyond that paid by Medicare for home health service and out-of-pocket spending for hired helpers, we followed a previous study by converting the participants' reported hours of informal care provided in the month before each interview to a 5-year total number of hours and multiplied this by the state's average costs of home health care services (mean, $20 per hour; range, $16 to $28) (15) . For sensitivity analysis, we replaced the statebased costs of nursing home (Medicaid and private payer) and home health care with the national averages. All measures of health care use and spending are therefore derived from individual Medicare claims data or self-reported data in the HRS. Where costs are not explicitly reported, we have used the validated imputation methods previously described to assign values.
We adjusted all expenditures for inflation (2010 U.S. dollars) based on the Consumer Price Index. We discounted spending to 5 years before death using a 3% discount rate. To compare the relative burden of out-of-pocket spending by household, we calculated the median of the ratio of discounted real out-of-pocket spending 5 years before death and divided this by household wealth, as measured closest to the fifth year before death. For sensitivity analysis, we also calculated this ratio for financial wealth, which excluded the equity value of the house. All reported values are adjusted for HRS sampling weights using the most recent weight available for each person (13) .
We considered the patterns of spending associated with sociodemographic factors in 2 ways. In our primary results, we examined spending across diseases and subgroups based on race, marital status, and education. Because patients with dementia are often older and have lower educational attainment, we also considered spending measures by disease (dementia and nondementia groups) and we adjusted these measures for age (5-year intervals), sex, race, education, marital status, and common coexisting conditions (stroke, diabetes, heart disease, hypertension, lung disease, cancer, psychiatric problems, and arthritis) using a ␥-distribution regression model.
Role of the Funding Source
The study was approved by the Mount Sinai School of Medicine Institutional Review Board, HRS Data Confidentiality Committee, and Centers for Medicare & Medicaid Services Privacy Board. The HRS is funded by the National Institute of Aging (NIA) and the Social Security Administration. The study investigators also received support from the NIA and the American Federation for Aging Research. Funding sources had no role in the design, conduct, and analysis of this study or in the decision to submit the manuscript for publication.
RESULTS
The dementia group included 555 participants with a greater than 50% probability of having dementia in the 5 years preceding death. The mean probability of dementia among this group was 87%; further, 59% of this group had probabilities of dementia greater than 90%. For the remaining participants (n = 1147), the mean probability of dementia was 12%. The primary causes of death among the nondementia group included cancer (n = 279), heart disease (n = 431), or other conditions (n = 437) ( Table 1 ). The dementia group was older at the time of death (88 years compared with 82, 85, and 83 years in the cancer, heart disease, and other conditions groups, respectively), was less likely to be married (25% compared with 44%, 35%, and 39%, respectively), and had lower median household wealth at the beginning of the study period ($115 942 compared with $243 168, $203 748, and $220 771, respectively). In addition, Medicaid enrollment was significantly higher among the dementia group at the start of the study period (21% compared with 8%, 8%, and 13%, respectively) and enrollment increased during the last 5 years of life (27% compared with 12%, 15%, and 15%, respectively). The mean adjusted total health care spending in the last 5 years of life was $287 038 among decedents with dementia and $183 001 among those in other disease groups ( Table 2 ). The mean adjusted total Medicare spending 5 years before death was similar across groups: $86 430 and $98 326 in the dementia and nondementia groups, respectively. However, average Medicaid, out-of-pocket, and informal care costs were higher for the dementia group ($35 346, $61 522, and $83 022, respectively) than for the nondementia group ($4552, $34 068, and $38 272, respectively). Absolute out-of-pocket spending was significantly higher in the dementia group, and such spending as a proportion of total household wealth 5 years before death was also substantially higher (median, 32% [dementia group] and 11% [nondementia group]). Out-of-pocket spending as a ratio of financial wealth (that is, excluding housing) was even larger (median, 242% [dementia group] and 81% [nondementia group]). Subcategories of outof-pocket spending are not reported here, but their patterns are consistent with those reported in our earlier work (8) .
In stratified analyses, the gap in out-of-pocket financial burdens between decedents with and without dementia was more pronounced for lower education and minority groups. Among persons with dementia and less than a high school education, median out-ofpocket spending accounted for almost half (48%) of wealth 5 years before death compared with 21% for those without dementia ( Table 2) . This difference was not as marked among those with a high school education or higher (median out-of-pocket spending, 24% and 9%, respectively). In addition, women with dementia who were unmarried at the time of death spent 58% of their wealth on out-of-pocket health-related costs, whereas those without dementia spent 21% and those with a surviving spouse spent 10% or less, regardless of dementia status. Black decedents in the dementia * Out-of-pocket spending as a percentage of wealth was calculated for each participant, then reported as the groups' median ratio. Spending was adjusted to 2010 dollars for inflation and discounted to 5 y before death. HRS (Health and Retirement Study) weights were used. † Imputed third-party payments for nursing home costs were included in total social costs but were not listed here separately.
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group spent even more wealth on out-of-pocket healthrelated costs (84%) than black decedents in the nondementia group (30%). Implicit costs of informal care varied considerably across sociodemographic subgroups. Average informal care for decedents with dementia ($83 022) was more than double the corresponding care for those without dementia ($38 272) (P < 0.001). For various subgroups, Figure 1 shows the combined out-ofpocket and implicit informal costs faced by families providing end-of-life care. Black decedents at high risk for dementia had much lower levels of out-of-pocket spending ($23 425) than nonblack decedents ($64 819), most likely because of fewer financial resources ( Table  2) . However, more informal care was provided in black households ($117 496) than in nonblack households ($80 038) (P < 0.001), so the combined value of out-ofpocket spending and informal care was nearly identical between the 2 groups. Further, a similar pattern of higher out-of-pocket spending and lower implicit informal care costs was also found for high school graduates compared with those who did not finish high school. Despite finding a marked tradeoff between outof-pocket spending (higher among nonblack persons and high school graduates) and informal care costs (higher among black persons and those with lower educational attainment), the total value of these 2 spending categories was similar across race and education groups.
Combined informal and out-of-pocket expenses, however, were substantially higher in married households. Figure 1 shows that out-of-pocket expenditures were slightly lower for married decedents with dementia than for unmarried decedents, but the costs of informal care were more than double for married women in the dementia group ($177 767 compared with $65 136 for married women at low risk for dementia). Similar patterns were seen in men. As a result, combined expenses (informal plus out-of-pocket) were considerably higher for married decedents than for those who were single. Figure 2 presents estimates of total spending for the dementia and nondementia groups, adjusted for age, sex, race, education, marital status, and coexisting conditions using a ␥-distribution regression model (Appendix Table 1 , available at www.annals.org). The adjusted overall spending for patients with dementia, $279 076, is closer to the adjusted spending for those without dementia, $185 801, with a gap of $93 275 over the entire 5-year period.
Finally, in sensitivity analyses using alternative cutoffs for defining the dementia group, we found that the same pattern of results held whether we limited the group to persons with a risk for dementia of 70% or greater (n = 456 vs. n = 555 [original sample]) or 90% or greater (n = 329) (Appendix Table 2 , available at www.annals.org). Sensitivity analyses using the national (instead of state) average prices for nursing home and 
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ORIGINAL RESEARCH caregiving costs produced slightly higher cost estimates for all disease groups and categories of spending, although the pattern of spending was unchanged.
DISCUSSION
We used the nationally representative HRS cohort to examine the total health care spending of beneficiaries who died at age 70 years or older. Over the last 5 years of life, total social costs for persons with dementia were more than $250 000 per person, which is 57% greater than the social costs associated with death from other diseases. Further, the financial burden for patients with dementia was greater than that for persons with other diseases in terms of out-of-pocket spending (in absolute terms and as a percentage of household wealth) and the implicit costs of informal caregiving. This gap in the financial burden between persons at high and low risk for dementia was larger in the groups most vulnerable to financial risk: those who were unmarried, were black, and had less than a high school education. Of note, the dementia group already had markedly less wealth and a greater percentage was enrolled in Medicaid, a proportion that only grew over time. This may be the result of care needs and expenses occurring before our 5-year look-back period.
Medicare provides nearly universal health care coverage for U.S. adults older than 65 years. However, it does not cover the health-related expenses most valuable to those with chronic diseases or life-limiting illnesses, such as home care services, equipment, and nonrehabilitative nursing home care. These uncovered (uninsured) needs are greatest among persons with dementia, which is a chronic disease characterized by many years of progressive functional decline and supportive care needs. Our findings clearly show that the predominant determinant of health care costs for the dementia group are nursing home and informal care costs, and these burdens are largely borne by individuals and families, particularly among vulnerable subgroups. This leads to more than half of all patients with dementia having "spent down" sufficiently to qualify for Medicaid by their time of death, including three quarters of persons belonging to racial minorities. Despite the presence of Medicaid, families of decedents with dementia who were black or who had lower educational attainment faced a larger burden of informal caregiving (16, 17) .
In a pioneering study of dementia costs, Hurd and colleagues (9) used a similarly broad measure of costs associated with caring for persons with dementia from the HRS cohort. They found that raising the probability of dementia from 0% to 100% leads to annual additional social costs between $41 689 and $56 290 per person per year, depending on the imputation method (9). Our estimated differential cost for the dementia group, $93 275 over 5 years, is considerably smaller than their annual estimate for 2 reasons. First, their measure is a hypothetical assignment that raises the probability of dementia from 0% to 100%. In contrast, we compare groups (nondementia and dementia) with a mean probability of dementia of 12% and 87%, respectively. Weighting their figures accordingly would reduce their estimates of dementia costs to between $31 267 and $42 218 annually, which is closer to, but still higher than, our estimates expressed on an annual basis. A more important explanation for the difference is that we are comparing dementia and nondementia groups in the last 5 years of life. Because members of our nondementia group were all within 5 years of death, they were probably sicker than the nondementia control group in the study by Hurd and colleagues, leading to a smaller difference in costs between the 2 This study has several limitations. First, because of data restrictions we do not have direct measures of Medicaid or private insurance payments for the decedents. The methods we used to impute these payers' expenses are limited to coverage for nursing home care and probably underrepresent actual spending. Although we capture private insurance premiums in our measure of out-of-pocket spending, these do not reflect the tremendous variability across our sample in the dollar amounts paid by private insurance for health care services. In addition, we do not have information on lost wages because of illness. Few of our decedents were still working 5 years before death, but caregivers may be forgoing job opportunities that pay considerably more on an hourly basis than what we imputed using home health care service rates.
Second, we measured only the probability of dementia and not whether the person actually had dementia. In theory, death certificate data could be used, but in practice, relatively few death certificates list dementia as the primary cause; instead, the cause of death reflects the more immediate diagnosis, such as pneumonia. To the extent that we included patients with true dementia in the nondementia group, the differences we found between the disease categories are understated. Finally, we were not able to measure the true value of the services or care provided to the patient, rather only the dollars spent.
Despite the slowing of growth in Medicare spending and a declining share of out-of-pocket expenditures during the 2000s, we find older persons facing large and highly variable expenditures as they approach the last years of life. Household health-related financial risk is greatest among the social groups least able to cope, which further contributes to the poverty of surviving spouses and a continued intergenerational cycle of poverty (18, 19) . Vast differences in spending by disease complicate the ability of individuals and families to plan and save for future health care expenses (8) . Ongoing discussion of Medicare policy and health care reform should acknowledge the considerable financial risk currently faced by aging Medicare beneficiaries and examine reforms that might mitigate these risks. 
